NACDS Urges DIR Fee Reform in Statement to House Ways and Means Committee Details opportunities to reduce patients’ out-of-pocket drug costs and to lower overall healthcare spending through DIR fee reform; Describes public’s trust of pharmacies’ cost-saving proposals

2019-02-12T17:07:13+00:00Feb-12-19|Categories: Press Release|Tags: , , , , |

NACDS today submitted a statement to the U.S. House of Representatives Committee on Ways and Means for the hearing titled “The Cost of Rising Prescription Drug Prices.”

NACDS, NCPA Thank Patient, Consumer Groups for Taking Important Stance on DIR Fee Reform Groups emphasize DIR fee reform’s power to reduce out-of-pocket drug costs and to reduce overall healthcare costs as a result of medication adherence and better health

2019-02-12T17:08:10+00:00Feb-12-19|Categories: Press Release|Tags: , , , , |

NACDS and the National Community Pharmacists Association (NCPA) today lauded 24 patient and consumer groups for advocating for pharmacy direct and indirect remuneration (DIR) fee reform.

NACDS, NCPA Praise Senate Action to Reduce Patient Drug Costs Bipartisan Senate letter to HHS Secretary urges swift action on pharmacy DIR fee reform to lower out-of-pocket drug costs for patients and to stop unworkable practices that are unfair to pharmacies

2019-02-12T17:08:57+00:00Feb-05-19|Categories: Press Release|Tags: , , , , |

NACDS and the National Community Pharmacists Association (NCPA) today praised a bipartisan Senate letter to Health and Human Services Secretary Alex Azar.

NACDS Provides Input on HHS’ Healthy People 2030 Initiative Highlights pharmacists’ increasing role as trusted, accessible and effective healthcare providers

2019-02-12T17:12:15+00:00Jan-28-19|Categories: Press Release|Tags: , |

NACDS has submitted comments containing recommendations for the Department of Health and Human Services’ (HHS) Healthy People 2030 initiative, which develops a new set of evidence-based, 10-year national objectives aimed at improving the health of all Americans.

NACDS Demonstrates Need for DIR Fee Reform in Comments to CMS Supports agency proposal to reduce patients’ out-of-pocket drug costs, reduce overall healthcare costs, improve patient health, and address drastically unfair reimbursement to pharmacies

2019-01-25T11:49:12+00:00Jan-25-19|Categories: Press Release|Tags: , , , |

Based on insights from member pharmacies that serve as the front lines of healthcare delivery, the National Association of Chain Drug Stores (NACDS) has submitted extensive and thoroughly documented

NACDS Addresses DIR Fees, Other “Access Agenda” Priorities in National Drug-Pricing Policy Discussion NACDS responds to request-for-information from HHS Secretary Azar for “Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs”

2018-07-18T16:25:32+00:00Jul-18-18|Categories: Press Release|Tags: , , , , |

NACDS has submitted comments to Health and Human Services Secretary Alex Azar in response to the agency’s request-for-information on drug-pricing public policy issues.

NACDS RxIMPACT Rallies Senate Support for Action on DIR Fees Urging Senators to sign letter to HHS Secretary is the most recent action of NACDS’ grassroots advocacy program on this pressing issue

2019-01-22T15:58:35+00:00Jul-11-18|Categories: Press Release|Tags: , , , , |

NACDS RxIMPACT pharmacy advocates are urging Senators to sign a letter to U.S. Secretary of Health and Human Services Secretary Alex Azar that is being led by Sen. Shelley Moore Capito (R-WV) and Sen. Jon Tester (D-MT).

Load More Posts